vs
Arcutis Biotherapeutics, Inc.(ARQT)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Arcutis Biotherapeutics, Inc.的季度营收约是Repay Holdings Corp的1.6倍($129.5M vs $78.6M),Arcutis Biotherapeutics, Inc.净利率更高(13.4% vs -178.3%,领先191.7%),Arcutis Biotherapeutics, Inc.同比增速更快(81.5% vs 0.4%),过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高(61.6% vs -1.3%)
Arcutis Biotherapeutics是一家临床阶段生物制药企业,专注于开发和商业化免疫介导皮肤病领域的创新处方疗法,产品管线覆盖银屑病、特应性皮炎、斑秃等适应症,主要服务美国市场的患者及医疗服务提供者,填补皮肤科诊疗领域的未满足需求。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
ARQT vs RPAY — 直观对比
营收规模更大
ARQT
是对方的1.6倍
$78.6M
营收增速更快
ARQT
高出81.1%
0.4%
净利率更高
ARQT
高出191.7%
-178.3%
两年增速更快
ARQT
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $129.5M | $78.6M |
| 净利润 | $17.4M | $-140.1M |
| 毛利率 | 91.0% | 74.2% |
| 营业利润率 | 14.2% | -182.2% |
| 净利率 | 13.4% | -178.3% |
| 营收同比 | 81.5% | 0.4% |
| 净利润同比 | 261.2% | -3304.1% |
| 每股收益(稀释后) | $0.14 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ARQT
RPAY
| Q4 25 | $129.5M | $78.6M | ||
| Q3 25 | $99.2M | $77.7M | ||
| Q2 25 | $81.5M | $75.6M | ||
| Q1 25 | $65.8M | $77.3M | ||
| Q4 24 | $71.4M | $78.3M | ||
| Q3 24 | $44.8M | $79.1M | ||
| Q2 24 | $30.9M | $74.9M | ||
| Q1 24 | $49.6M | $80.7M |
净利润
ARQT
RPAY
| Q4 25 | $17.4M | $-140.1M | ||
| Q3 25 | $7.4M | $-6.4M | ||
| Q2 25 | $-15.9M | $-102.3M | ||
| Q1 25 | $-25.1M | $-7.9M | ||
| Q4 24 | $-10.8M | $-4.1M | ||
| Q3 24 | $-41.5M | $3.2M | ||
| Q2 24 | $-52.3M | $-4.1M | ||
| Q1 24 | $-35.4M | $-5.2M |
毛利率
ARQT
RPAY
| Q4 25 | 91.0% | 74.2% | ||
| Q3 25 | 91.2% | 74.4% | ||
| Q2 25 | 90.8% | 75.7% | ||
| Q1 25 | 86.6% | 75.9% | ||
| Q4 24 | 90.3% | 76.3% | ||
| Q3 24 | 87.7% | 77.8% | ||
| Q2 24 | 88.8% | 78.2% | ||
| Q1 24 | 93.4% | 76.2% |
营业利润率
ARQT
RPAY
| Q4 25 | 14.2% | -182.2% | ||
| Q3 25 | 8.6% | -3.9% | ||
| Q2 25 | -17.9% | -138.7% | ||
| Q1 25 | -37.3% | -4.7% | ||
| Q4 24 | -10.7% | -1.5% | ||
| Q3 24 | -87.3% | -0.9% | ||
| Q2 24 | -162.3% | -4.6% | ||
| Q1 24 | -63.8% | -3.1% |
净利率
ARQT
RPAY
| Q4 25 | 13.4% | -178.3% | ||
| Q3 25 | 7.5% | -8.3% | ||
| Q2 25 | -19.5% | -135.2% | ||
| Q1 25 | -38.1% | -10.3% | ||
| Q4 24 | -15.1% | -5.3% | ||
| Q3 24 | -92.8% | 4.1% | ||
| Q2 24 | -169.6% | -5.4% | ||
| Q1 24 | -71.4% | -6.5% |
每股收益(稀释后)
ARQT
RPAY
| Q4 25 | $0.14 | $-1.68 | ||
| Q3 25 | $0.06 | $-0.08 | ||
| Q2 25 | $-0.13 | $-1.15 | ||
| Q1 25 | $-0.20 | $-0.09 | ||
| Q4 24 | $-0.09 | $-0.04 | ||
| Q3 24 | $-0.33 | $0.03 | ||
| Q2 24 | $-0.42 | $-0.04 | ||
| Q1 24 | $-0.32 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $115.7M |
| 总债务越低越好 | $109.0M | $280.1M |
| 股东权益账面价值 | $189.5M | $484.4M |
| 总资产 | $433.0M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.58× | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
ARQT
RPAY
| Q4 25 | $42.9M | $115.7M | ||
| Q3 25 | $47.1M | $95.7M | ||
| Q2 25 | $72.7M | $162.6M | ||
| Q1 25 | $53.1M | $165.5M | ||
| Q4 24 | $71.3M | $189.5M | ||
| Q3 24 | $134.9M | $168.7M | ||
| Q2 24 | $84.3M | $147.1M | ||
| Q1 24 | $190.1M | $128.3M |
总债务
ARQT
RPAY
| Q4 25 | $109.0M | $280.1M | ||
| Q3 25 | $108.5M | $279.5M | ||
| Q2 25 | $108.0M | $279.0M | ||
| Q1 25 | $107.6M | $497.6M | ||
| Q4 24 | $107.2M | $496.8M | ||
| Q3 24 | $204.6M | $496.2M | ||
| Q2 24 | $203.8M | $435.6M | ||
| Q1 24 | $202.8M | $434.9M |
股东权益
ARQT
RPAY
| Q4 25 | $189.5M | $484.4M | ||
| Q3 25 | $158.1M | $616.9M | ||
| Q2 25 | $139.0M | $633.7M | ||
| Q1 25 | $142.7M | $755.7M | ||
| Q4 24 | $157.5M | $761.3M | ||
| Q3 24 | $156.6M | $754.7M | ||
| Q2 24 | $186.4M | $815.4M | ||
| Q1 24 | $224.9M | $813.8M |
总资产
ARQT
RPAY
| Q4 25 | $433.0M | $1.2B | ||
| Q3 25 | $371.0M | $1.3B | ||
| Q2 25 | $352.4M | $1.4B | ||
| Q1 25 | $344.1M | $1.5B | ||
| Q4 24 | $348.9M | $1.6B | ||
| Q3 24 | $437.4M | $1.6B | ||
| Q2 24 | $444.8M | $1.5B | ||
| Q1 24 | $478.5M | $1.5B |
负债/权益比
ARQT
RPAY
| Q4 25 | 0.58× | 0.58× | ||
| Q3 25 | 0.69× | 0.45× | ||
| Q2 25 | 0.78× | 0.44× | ||
| Q1 25 | 0.75× | 0.66× | ||
| Q4 24 | 0.68× | 0.65× | ||
| Q3 24 | 1.31× | 0.66× | ||
| Q2 24 | 1.09× | 0.53× | ||
| Q1 24 | 0.90× | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $26.2M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | — | $23.2M |
| 自由现金流率自由现金流/营收 | — | 29.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势,按日历期对齐
经营现金流
ARQT
RPAY
| Q4 25 | $26.2M | $23.3M | ||
| Q3 25 | $-1.8M | $32.2M | ||
| Q2 25 | $324.0K | $33.1M | ||
| Q1 25 | $-30.4M | $2.5M | ||
| Q4 24 | $-748.0K | $34.3M | ||
| Q3 24 | $-34.7M | $60.1M | ||
| Q2 24 | $-45.1M | $31.0M | ||
| Q1 24 | $-31.6M | $24.8M |
自由现金流
ARQT
RPAY
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | $246.0K | $33.0M | ||
| Q1 25 | $-31.0M | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | $-34.8M | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率
ARQT
RPAY
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | 0.3% | 43.6% | ||
| Q1 25 | -47.1% | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | -77.8% | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度
ARQT
RPAY
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.1% | 0.1% | ||
| Q1 25 | 0.9% | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.0% | 0.6% | ||
| Q1 24 | 0.0% | 0.1% |
现金转化率
ARQT
RPAY
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARQT
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |